Clinical Trial 10089

Ventura, CA 93003

Study Summary:

Parkinson’s Disease (PD) affects an estimated 4-6 million people and their families all over the world. While there is still no cure, participating in clinical trials can help future generations better understand and develop treatments for this debilitating condition.

Researchers at approximately 143 clinics around the world are currently helping test the safety and effectiveness of an investigational medication for the symptoms of Parkinson’s Disease. Different dose levels of the investigational medication will be compared to Rasagiline (an approved medication) and placebo (looks like the investigational medication but does not contain the active ingredient).

The primary objective of this study is to see if participants in the study drug groups have greater symptomatic improvement compared to participants in the placebo group.

You or someone in your care may be able to participate in this study. The people who may qualify for this study:

  • Are 30-85 years old.
  • Have received a diagnosis of Parkinson’s Disease no more than 5 years ago.
  • Are experiencing symptoms of slowed movement (bradykinesia) and have problems with balance, muscular rigidity (stiffness), or a resting tremor.
tumblr hit tracking tool

Qualified Participants May Receive:

Study-related medication and study-related procedures at no cost.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.